Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
Paycom Software (PAYC) shares advanced as KeyBanc upgraded the stock and raised the price target on optimism about sales, ...
Key Takeaways DexCom received a warning letter from the Food and Drug Administration following inspections of two of its ...
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
The U.S. Department of Agriculture has dissolved two key food safety advisory committees, sparking concern over government ...
The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...
BofA keeps a Buy rating on DexCom (DXCM) with a $105 price target after Dexcom announced it received a warning letter from the FDA.
Dexcom (Nadsaq:DXCM) announced today that it received a warning letter from the FDA following inspections of two company ...
The investor has been working behind the scenes at the tech-services firm and isn't currently planning to nominate directors. The regulator said Robinhood had violated "numerous" rules, including ...
Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...
In a regulatory filing, DexCom (DXCM) disclosed that on March 4, the company received a warning letter from the U.S. FDA following inspections ...
DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results